HIT Consultant June 23, 2025
What You Should Know:
– After decades of relentless increases, diabetes-related healthcare costs have finally plateaued, according to a new analysis by Nomi Health. The key finding from the company’s latest “Trends in Spend” report marks a rare moment of opportunity for self-funded employers to re-evaluate how they manage one of their highest-cost conditions before the next wave of expenses hits.
– Analyzing employer-sponsored claims data from 2021–2024, Nomi Health found that while overall healthcare costs continue to climb, diabetes spending has leveled off, ending a long-standing trend of rising costs.
Shift in Diabetes-Related Spending
For the first time, diabetes-related spending is flattening faster than non-diabetic spend, completely reversing the previous pattern where diabetes costs outpaced everything else by...
Today's Sponsors
Today's Sponsor